PriceTargets.com logo

Cerence - CRNC Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $8.41
  • Forecasted Upside: 66.91%
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 7 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$5.04 As of 11/21/2024 01:15 PM ET
▲ +2.22 (78.72%)

This chart shows the closing price for CRNC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cerence Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CRNC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CRNC

Analyst Price Target is $8.41
▲ +66.91% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Cerence in the last 3 months. The average price target is $8.41, with a high forecast of $23.00 and a low forecast of $3.00. The average price target represents a 66.91% upside from the last price of $5.04.

This chart shows the closing price for CRNC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 8 contributing investment analysts is to hold stock in Cerence. This rating has held steady since January 2024, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
8/22/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/9/2024TD CowenLower TargetBuy ➝ Buy$12.00 ➝ $10.00
8/9/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$6.50 ➝ $3.30
8/9/2024Needham & Company LLCReiterated RatingHold
7/15/2024Evercore ISILower TargetIn-Line ➝ In-Line$8.00 ➝ $5.00
7/12/2024Robert W. BairdLower TargetNeutral ➝ Neutral$8.00 ➝ $6.00
7/10/2024The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$6.00 ➝ $3.00
5/13/2024The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$19.00 ➝ $6.00
5/10/2024Craig HallumLower TargetHold ➝ Hold$22.00 ➝ $8.00
5/10/2024WedbushLower TargetNeutral ➝ Neutral$21.00 ➝ $9.00
5/10/2024Robert W. BairdLower TargetNeutral ➝ Neutral$15.00 ➝ $8.00
5/10/2024Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$25.00 ➝ $6.50
5/7/2024Needham & Company LLCReiterated RatingBuy ➝ Hold
4/17/2024Robert W. BairdLower TargetNeutral ➝ Neutral$17.00 ➝ $15.00
3/15/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$23.00
2/7/2024WedbushBoost TargetNeutral ➝ Neutral$19.00 ➝ $21.00
2/7/2024Craig HallumDowngradeBuy ➝ Hold$22.00
11/29/2023The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$28.00 ➝ $19.00
11/28/2023Craig HallumLower TargetBuy ➝ Buy$38.00 ➝ $25.00
11/28/2023WedbushLower TargetNeutral ➝ Neutral$31.00 ➝ $19.00
11/28/2023Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$32.00 ➝ $25.00
11/28/2023Needham & Company LLCLower TargetBuy ➝ Buy$34.00 ➝ $23.00
5/11/2023888Reiterated RatingMaintains
5/11/2023WedbushLower Target$32.00 ➝ $26.00
3/3/2023Needham & Company LLCReiterated RatingBuy$42.00
2/10/2023WedbushBoost TargetNeutral$25.00 ➝ $32.00
2/9/2023The Goldman Sachs GroupBoost TargetNeutral$19.00 ➝ $31.00
2/9/2023Craig HallumUpgradeHold ➝ Buy$24.00 ➝ $40.00
2/9/2023Needham & Company LLCBoost TargetBuy$40.00 ➝ $42.00
2/9/2023Wells Fargo & CompanyBoost TargetOverweight$25.00 ➝ $32.00
2/9/2023Robert W. BairdBoost TargetNeutral$23.00 ➝ $30.00
11/30/2022The Goldman Sachs GroupBoost TargetNeutral$17.00 ➝ $19.00
11/30/2022Needham & Company LLCBoost TargetBuy$30.00 ➝ $40.00
11/15/2022Wells Fargo & CompanyLower TargetOverweight$48.00 ➝ $25.00
10/11/2022The Goldman Sachs GroupLower TargetNeutral$30.00 ➝ $17.00
8/15/2022CowenLower Target$32.00
8/10/2022WedbushLower Target$32.00 ➝ $25.00
8/10/2022Wells Fargo & CompanyLower TargetOverweight$64.00 ➝ $48.00
8/10/2022The Goldman Sachs GroupLower TargetNeutral$34.00 ➝ $30.00
8/10/2022Craig HallumDowngradeBuy ➝ Hold$45.00 ➝ $24.00
8/10/2022Needham & Company LLCLower TargetBuy$46.00 ➝ $30.00
8/10/2022Raymond JamesDowngradeOutperform ➝ Market Perform
7/11/2022Wells Fargo & CompanyLower TargetOverweight$66.00 ➝ $64.00
7/7/2022Royal Bank of CanadaUpgradeUnderperform ➝ Sector Perform$28.00 ➝ $27.00
5/11/2022Craig HallumLower Target$52.00 ➝ $45.00
5/11/2022WedbushLower Target$45.00 ➝ $32.00
4/1/2022Wells Fargo & CompanyLower TargetOverweight$68.00 ➝ $67.00
2/21/2022The Goldman Sachs GroupDowngradeBuy ➝ Neutral$53.00 ➝ $44.00
2/9/2022Needham & Company LLCLower TargetBuy$165.00 ➝ $78.00
2/8/2022WedbushDowngradeOutperform ➝ Neutral$115.00 ➝ $45.00
2/8/2022Jefferies Financial GroupDowngradeBuy ➝ Hold$115.00 ➝ $40.00
2/8/2022Robert W. BairdDowngradeOutperform ➝ Neutral$110.00 ➝ $50.00
2/8/2022Raymond JamesLower TargetOutperform$100.00 ➝ $76.00
2/8/2022Royal Bank of CanadaDowngradeSector Perform ➝ Underperform$77.00 ➝ $37.00
1/14/2022Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$95.00 ➝ $77.00
1/12/2022Needham & Company LLCReiterated RatingBuy$165.00
1/10/2022The Goldman Sachs GroupLower TargetBuy$115.00 ➝ $103.00
12/30/2021Raymond JamesReiterated RatingOutperform$100.00
12/16/2021Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$85.00
12/7/2021Raymond JamesUpgradeMarket Perform ➝ Outperform$100.00
11/23/2021Needham & Company LLCReiterated RatingBuy$164.00
11/23/2021Craig HallumLower TargetBuy$145.00 ➝ $135.00
11/23/2021The Goldman Sachs GroupLower TargetBuy$134.00 ➝ $115.00
11/23/2021WedbushLower TargetIn-Line ➝ Outperform$140.00 ➝ $115.00
11/23/2021Wells Fargo & CompanyLower TargetEqual Weight$95.00 ➝ $91.00
11/23/2021Royal Bank of CanadaLower TargetOutperform$110.00 ➝ $95.00
10/6/2021Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$112.00 ➝ $110.00
10/5/2021Wells Fargo & CompanyLower TargetEqual Weight$113.00 ➝ $95.00
9/15/2021Jefferies Financial GroupInitiated CoverageBuy$140.00
9/10/2021Wells Fargo & CompanyLower TargetEqual Weight$115.00 ➝ $113.00
8/16/2021Evercore ISIBoost TargetPositive ➝ Outperform$125.00 ➝ $150.00
8/10/2021WedbushReiterated RatingOutperform
8/10/2021Robert W. BairdBoost TargetOutperform$122.00 ➝ $135.00
8/10/2021Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$108.00 ➝ $115.00
8/10/2021Craig HallumBoost TargetBuy$135.00 ➝ $145.00
8/10/2021Needham & Company LLCBoost TargetBuy$155.00 ➝ $165.00
8/10/2021Royal Bank of CanadaBoost TargetSector Perform$105.00 ➝ $114.00
7/7/2021Raymond JamesDowngradeOutperform ➝ Market Perform$115.00
6/3/2021Robert W. BairdInitiated CoverageOutperform$122.00
5/24/2021Evercore ISIUpgradeIn-Line ➝ Outperform$125.00
5/18/2021Evercore ISIUpgradeIn-Line ➝ Outperform$125.00
5/17/2021WedbushLower TargetOutperform$150.00 ➝ $130.00
5/11/2021WedbushLower TargetOutperform$150.00 ➝ $130.00
3/31/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$100.00
3/25/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$100.00
3/17/2021Berenberg BankUpgradeHold ➝ Buy$117.00
3/11/2021Berenberg BankUpgradeHold ➝ Buy$117.00
2/25/2021Needham & Company LLCBoost TargetBuy$125.00 ➝ $155.00
2/19/2021Needham & Company LLCBoost TargetBuy$125.00 ➝ $155.00
2/10/2021Raymond JamesBoost TargetOutperform$80.00 ➝ $130.00
2/9/2021Craig HallumBoost TargetBuy$90.00 ➝ $135.00
2/9/2021Needham & Company LLCBoost TargetBuy$120.00 ➝ $125.00
2/9/2021WedbushBoost TargetOutperform$120.00 ➝ $150.00
2/9/2021Royal Bank of CanadaBoost TargetSector Perform$88.00 ➝ $105.00
1/15/2021Needham & Company LLCBoost TargetBuy$95.00 ➝ $120.00
12/23/2020WedbushBoost TargetOutperform$90.00 ➝ $120.00
12/10/2020Berenberg BankInitiated CoverageHold$93.00
11/18/2020The Goldman Sachs GroupUpgradeSell ➝ Buy$82.00
11/17/2020Craig HallumBoost Target$61.00 ➝ $90.00
11/17/2020WedbushBoost TargetOutperform$75.00 ➝ $90.00
11/17/2020Needham & Company LLCBoost TargetBuy$82.00 ➝ $95.00
11/17/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$55.00 ➝ $72.00
11/17/2020Raymond JamesBoost TargetOutperform$56.00 ➝ $80.00
10/23/2020WedbushBoost TargetOutperform$60.00 ➝ $75.00
10/16/2020Needham & Company LLCInitiated CoverageBuy$82.00 ➝ $82.00
8/5/2020Craig HallumBoost TargetBuy$27.00 ➝ $61.00
8/5/2020Raymond JamesBoost TargetOutperform$40.00 ➝ $56.00
6/30/2020Royal Bank of CanadaInitiated CoverageOutperform$50.00
6/29/2020The Goldman Sachs GroupBoost Target$17.00 ➝ $26.00
6/8/2020Jefferies Financial GroupInitiated CoverageBuy$47.00
6/1/2020CowenBoost TargetOutperform$28.00 ➝ $39.00
5/27/2020WedbushBoost TargetOutperform$27.00 ➝ $40.00
5/26/2020Raymond JamesDowngradeStrong-Buy ➝ Outperform
5/12/2020CowenInitiated CoverageOutperform$28.00
2/14/2020Evercore ISIInitiated CoverageBuy$24.00
2/12/2020WedbushReiterated RatingBuy$27.00
1/7/2020The Goldman Sachs GroupInitiated CoverageSell$17.00
12/18/2019Craig HallumInitiated CoverageBuy$24.00
12/18/2019WedbushReiterated RatingOutperform
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.12 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024
  • 1 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 1 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 1 very positive mentions
  • 5 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
10/22/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024

Current Sentiment

  • 0 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Cerence logo
Cerence Inc. provides AI powered virtual assistants for the mobility/transportation market in United States, Other Americas, Germany, Europe, Middle East, Africa, Japan, and Other Asia-Pacific. The company offers edge software components, cloud-connected components, virtual assistant coexistence, and professional services. It also provides conversational artificial intelligence-based solutions, including speech recognition, natural language understanding, speech signal enhancement, text-to-speech, and acoustic modeling technology. Cerence Inc. is headquartered in Burlington, Massachusetts.
Read More

Today's Range

Now: $5.04
Low: $3.40
High: $5.60

50 Day Range

MA: $3.00
Low: $2.44
High: $3.80

52 Week Range

Now: $5.04
Low: $2.34
High: $21.67

Volume

37,776,738 shs

Average Volume

1,359,932 shs

Market Capitalization

$210.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.36

Frequently Asked Questions

What sell-side analysts currently cover shares of Cerence?

The following equities research analysts have issued research reports on Cerence in the last twelve months: Craig Hallum, Evercore ISI, Needham & Company LLC, Robert W. Baird, TD Cowen, The Goldman Sachs Group, Inc., Wedbush, and Wells Fargo & Company.
View the latest analyst ratings for CRNC.

What is the current price target for Cerence?

0 Wall Street analysts have set twelve-month price targets for Cerence in the last year. Their average twelve-month price target is $8.41, suggesting a possible upside of 103.2%. Needham & Company LLC has the highest price target set, predicting CRNC will reach $23.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $3.00 for Cerence in the next year.
View the latest price targets for CRNC.

What is the current consensus analyst rating for Cerence?

Cerence currently has 7 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CRNC, but not buy more shares or sell existing shares.
View the latest ratings for CRNC.

What other companies compete with Cerence?

Other companies that are similar to Cerence include EverQuote, OneSpan, ECARX, Rackspace Technology and Magic Software Enterprises. Learn More about companies similar to Cerence.

How do I contact Cerence's investor relations team?

Cerence's physical mailing address is 15 WAYSIDE ROAD, BURLINGTON MA, 01803. The company's listed phone number is 857-362-7300 and its investor relations email address is [email protected]. The official website for Cerence is www.cerence.com. Learn More about contacing Cerence investor relations.